Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Protagenic Therapeutics Inc (ID) PTIXW


Primary Symbol: PTIX

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News ()

Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market

ACCESS Newswire 6 hours ago

Results from Phase 1 Multiple-Dose Study of PT00114

ACCESS Newswire December 9, 2025

Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study

ACCESS Newswire November 13, 2025

Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

ACCESS Newswire August 22, 2025

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

ACCESS Newswire August 21, 2025

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

GlobeNewswire July 30, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, TXNM, SVT, PTIX on Behalf of Shareholders

GlobeNewswire May 27, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq - INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq - PTIX)

GlobeNewswire May 27, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, TXNM, SVT, PTIX on Behalf of Shareholders

PR Newswire May 22, 2025

Opinion & Analysis ()

No current opinion is available.

Bullboard Posts ()

RE:RE:PTIX....early a.m runner in PB mode

No position
Iseneschal - May 20, 2025

RE:PTIX....early a.m runner in PB mode

Trading lower this a.m .... $8.80....volume has decreased dramatically
Iseneschal - May 20, 2025

PTIX.....LoL Volume & Price Action...the 2 best indicators !

Scalp #2
Iseneschal - May 19, 2025

PTIX..... Go ahead do what you want to do

I'm watching this...no position Cheers !
Iseneschal - May 19, 2025

PTIX....2 xa's tap on H.O.D $11.67....now $9.65 & Halted

Volumes are decreasing My previous support targets are still valid Cheers !
Iseneschal - May 19, 2025

PTIX....LoL

should hung in there for an extra minute or 2
Iseneschal - May 19, 2025